Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia - Bastit, L; Vandebroek, A; Altintas, S; Gaede, B; Pintér, T; Suto, TS (J Clin Oncol., 2008)
et al.